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Based on a national audit of chronic heart failure (CHF) management programmes 
(CHF-MPs) conducted in 2006, Driscoll et al identified a disproportionate distribution 
ranging from 0 to 4.2 programmes/million population in the various states of Australia 
with many programmes not following best practice.1 We welcome their proposal to 
develop national benchmarks for CHF management and acknowledge the 
contributions of the Heart Foundation and health professionals in finalising these 
recommendations.2 We would like to share the Queensland experience in striving 
towards best practice with the number of CHF-MPs increasing from four (at the time 
of the 2006 survey) to 23, equating to 5.0 programmes/million population. 
Queensland now has a state-wide heart failure service steering committee with a focus 
on the development of CHF-MPs supported by a central coordinator.  
In a randomised controlled trial of low-risk CHF patients, nurse care management 
failed to reduce all-cause or heart failure related hospitalisation.3 Despite this, 16% of 
CHF-MPs in Australia enrolled New York Heart Association functional class I 
patients.1 While it is acknowledged that New York Heart Association functional class 
is one of many variables that determines the risk of rehospitalisation, 20% of these 
patients had not had an echocardiogram to confirm the diagnosis. A survey of 
Queensland CHF-MPs in 2010 found that 17% of programmes seldom have an 
echocardiogram prior to referral. This remains a geographical challenge for a state 
that is over seven times larger than the UK, and is being addressed through our 
clinical networks.  
The importance of achieving target doses of ACE inhibitors, angiotensin receptor 
blockers and β blockers in CHF is well established. Nurse-assisted models can 
facilitate this process; however, only 44% of CHF-MPs allowed heart failure nurses to 
titrate medications.1 Driscoll et al evaluated medications titrated, but not whether 
target doses were achieved. An audit of titration outcomes of patients with systolic 
CHF newly referred to four CHF-MPs in Brisbane between June and December 2009 
found that of patients not on target doses at hospital discharge, only a quarter achieved 
target doses within 6 months. We are currently evaluating a number of quality 
initiatives to improve uptitration following hospital discharge.4 
Driscoll et al reported that while all CHF-MPs had nurses, involvement of doctors and 
allied health professionals ranged from 14% to 50%.1 A Queensland survey of CHF-
MP team leaders' perceptions conducted in May 2010 suggested reasonable access to 
medical support (general practitioners 91%, specialist physicians 87%), but variable 
access to allied health ranging from 36% for psychology to 78% for pharmacy. Video-
conference clinics provided by staff in tertiary centres are now being used to address 
workforce shortages in rural and regional areas.  
With the rapid expansion of new CHF-MPs, there remains significant variation in 
implementation. Approaches to patient selection and medication titration should be 
addressed through state-wide and national standards. Continued advocacy is required 
to improve access to diagnostic investigations and appropriately trained health 
professionals, which may include using tele-health in geographically isolated 
centres.5 
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